Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07825363) titled 'Clinical Evaluation of NIRSense Tissue Oximetry Sensor Monitoring to Early Detect Cardiogenic Shock' on Sept. 13.

Study Type: Observational

Primary Sponsor: NIRSense Inc.

Condition: Cardiogenic Shock Acute Myocardial Infarction Acute Decompensated Heart Failure

Intervention: Device: NIRSense Tissue Oximetry Sensor System

Recruitment Status: Recruiting

Date of First Enrollment: June 17, 2025

Target Sample Size: 20

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07825363

Published by HT Digital Content Services with permission from Health Daily Digest....